idw – Informationsdienst Wissenschaft

Nachrichten, Termine, Experten

Grafik: idw-Logo
Grafik: idw-Logo

idw - Informationsdienst
Wissenschaft

idw-Abo

idw-News App:

AppStore

Google Play Store



Instanz:
Teilen: 
16.02.2009 11:50

Mechanisms that prevent Alzheimer's Disease: Enzymatic activity plays key role

Petra Giegerich Presse- und Öffentlichkeitsarbeit
Johannes Gutenberg-Universität Mainz

    Journal of Alzheimer's Disease (JAD) publishes new findings on the protective effects of the enzyme alpha-secretase

    In a project involving the collaboration of several institutes, research scientists of the Johannes Gutenberg University Mainz have succeeded in gaining further insight in the functioning of endogenous mechanisms that protect against the development of Alzheimer's disease. It was found that the activity of the enzyme alpha-secretase is mainly responsible for the protective effect. "In the past, we had already postulated that the enzyme alpha-secretase was involved in preventing the formation of the cerebral plaques characteristic of Alzheimer's disease and also enhanced cerebral functions, such as learning and memory capacity," explains Professor Falk Fahrenholz of the Institute of Biochemistry at Mainz University. His research group has been working in cooperation with the University Medicine's Clinic of Psychiatry and Psychotherapy and the Central Animal Laboratory Facility (ZVTE) to discover the causes of these beneficial effects of alpha-secretase. The specialist publication Journal of Alzheimer's Disease (JAD) presents the results of this project in its latest issue, to appear in February 2009.

    The alpha-secretase is an endogenous enzyme that is present in the nerve cells of the brain, where it is responsible for the cleavage of a specific protein. The result is a soluble protein fragment that promotes the growth of nerve cells and thus prevents the development of cerebral deterioration. However, if the enzyme beta-secretase is active, a chain reaction is initiated that subsequently results in the development of Alzheimer's disease and, in most cases, in the complete loss of memory capacity. "You could say that alpha-secretase is the good enzyme and that beta-secretase is the bad enzyme," Fahrenholz comments. "We now want to find out how to activate this 'good' enzyme or increase its concentrations in the brain as a way of combating this disease."

    With this in view, the collaborating partners have been investigating whether the positive effects of alpha-secretase are attributable to its enzymatic activity or whether the protective effect is due to other properties of the enzyme. Enzymes play an important role in the metabolism as they control, regulate, and catalyze numerous biochemical processes. "The alpha-secretase enzyme is a highly complex one, with many other functions. For example, it also relays signals from the intercellular space into cells and interacts with molecules on other cells." Following investigations in a transgenic mouse model, Fahrenholz and his colleagues have now established that it is the enzymatic activity alone that guarantees the protective effects. If this activity is neutralized, the laboratory mice exhibit the symptoms that are characteristic of Alzheimer's disease: impaired learning ability, poor memory capacity, and the build-up of plaques. It is thus possible that the enzymatic activity of alpha-secretase could represent the starting point for the development of future treatments.

    At the same time, the researchers were able to confirm with their experiments that it is not the plaque build-up itself that is responsible for the loss of memory capacity. The cytotoxic substances that accumulate in plaques only destroy neuron synapses when they are still in solution. Professor Fahrenholz concludes: "It is important to consider other aspects in addition to the plaques themselves, particularly their precursors, which are a real cause of the disease."

    Original publication:
    Anja Schroeder, Falk Fahrenholz, Ulrich Schmitt
    Effect of a dominant-negative form of ADAM10 in a mouse model of Alzheimer's Disease
    Journal of Alzheimer's Disease, February 2009, Volume 16:02


    Weitere Informationen:

    http://www.j-alz.com


    Bilder

    Merkmale dieser Pressemitteilung:
    Biologie, Chemie, Medizin, Psychologie
    überregional
    Forschungsergebnisse, Kooperationen
    Englisch


     

    Hilfe

    Die Suche / Erweiterte Suche im idw-Archiv
    Verknüpfungen

    Sie können Suchbegriffe mit und, oder und / oder nicht verknüpfen, z. B. Philo nicht logie.

    Klammern

    Verknüpfungen können Sie mit Klammern voneinander trennen, z. B. (Philo nicht logie) oder (Psycho und logie).

    Wortgruppen

    Zusammenhängende Worte werden als Wortgruppe gesucht, wenn Sie sie in Anführungsstriche setzen, z. B. „Bundesrepublik Deutschland“.

    Auswahlkriterien

    Die Erweiterte Suche können Sie auch nutzen, ohne Suchbegriffe einzugeben. Sie orientiert sich dann an den Kriterien, die Sie ausgewählt haben (z. B. nach dem Land oder dem Sachgebiet).

    Haben Sie in einer Kategorie kein Kriterium ausgewählt, wird die gesamte Kategorie durchsucht (z.B. alle Sachgebiete oder alle Länder).